AMWL icon

American Well

7.33 USD
+0.03
0.41%
At close Apr 30, 4:00 PM EDT
1 day
0.41%
5 days
-5.91%
1 month
-6.98%
3 months
-36.97%
6 months
-24.04%
Year to date
4.12%
1 year
-28.21%
5 years
-98.41%
10 years
-98.41%
 

About: American Well Corp is a telehealth company enabling digital delivery of care for its customers. Its platform, Amwell, digital care delivery solution that equips health systems, health plans, government, and innovator clients with the tools to enable new models of care for their patients and members enabling care delivery across the full healthcare continuum - from primary and urgent care in the home to high acuity specialty consults, such as telestroke and telepsychiatry, in the hospital. It provides both on-demand and scheduled consultations. Its Health Plan Programs include Virtual Primary Care, Musculoskeletal Care, Dermatology Care, and Chronic Care among others.

Employees: 877

0
Funds holding %
of 7,425 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

33% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 9

5% more funds holding

Funds holding: 62 [Q3] → 65 (+3) [Q4]

0.17% less ownership

Funds ownership: 48.97% [Q3] → 48.79% (-0.17%) [Q4]

19% less call options, than puts

Call options by funds: $231K | Put options by funds: $285K

23% less repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 22

27% less capital invested

Capital invested by funds: $65.8M [Q3] → $48.4M (-$17.4M) [Q4]

33% less funds holding in top 10

Funds holding in top 10: 3 [Q3] → 2 (-1) [Q4]

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$7.50
2%
upside
Avg. target
$8.75
19%
upside
High target
$10
36%
upside

2 analyst ratings

positive
0%
neutral
100%
negative
0%
Truist Securities
Jailendra Singh
34% 1-year accuracy
12 / 35 met price target
2%upside
$7.50
Hold
Maintained
10 Apr 2025
Stifel
David Grossman
44% 1-year accuracy
7 / 16 met price target
36%upside
$10
Hold
Maintained
13 Feb 2025

Financial journalist opinion

Neutral
GlobeNewsWire
6 days ago
Amwell® to participate in upcoming investor conferences
BOSTON, April 24, 2025 (GLOBE NEWSWIRE) -- Amwell ®  (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, will participate in the following upcoming investor conferences:   On May 8, Mark Hirschhorn, chief financial officer and chief operating officer, will participate in one-on-one meetings at the Needham & Co. Virtual Technology and Services Conference held virtually.  On June 24, Hirschhorn will participate in the Truist Securities Healthcare Disruptors & Digital Health Conference in New York City.
Amwell® to participate in upcoming investor conferences
Neutral
GlobeNewsWire
1 week ago
Amwell® to report first quarter 2025 operating results
BOSTON, April 17, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leader in digital care, will report first quarter 2025 operating results after stock market trading hours on Thursday, May 1 2025. Following the distribution of the earnings alert via wire services, the Amwell management team will host a live conference call and webcast at 5 p.m.
Amwell® to report first quarter 2025 operating results
Neutral
GlobeNewsWire
1 month ago
Amwell makes inducement grant
BOSTON, March 03, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leader in technology-enabled care, today announced that, on March 3, 2025, it made a grant of restricted stock units (“RSUs”) covering 220,844 shares of its Class A common stock to Dan Zamansky. The grant was offered as material inducement to Zamansky's employment as Amwell's chief product and technology officer.
Amwell makes inducement grant
Neutral
GlobeNewsWire
1 month ago
Amwell announces innovation leader as chief product and technology officer
BOSTON, March 03, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leader in technology-enabled care, announced Dan Zamansky, an industry leader in innovation and technology, as the company's new chief product and technology officer, effective today. Zamansky will lead the company's product and R&D organizations.
Amwell announces innovation leader as chief product and technology officer
Neutral
GlobeNewsWire
2 months ago
Amwell® makes grants to new employees under inducement plan
BOSTON, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Amwell ®  (NYSE: AMWL), a leading technology-enabled care platform provider, announced that on Feb. 18, Amwell made grants of RSUs covering an aggregate of 16,737 shares of its Class A common stock to four new employees. The grants were offered as material inducement to the employees' employment with Amwell.
Amwell® makes grants to new employees under inducement plan
Neutral
GlobeNewsWire
2 months ago
Amwell® to participate in upcoming investor conference
BOSTON, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, will participate in an upcoming investor conference. Ido Schoenberg, M.D.
Amwell® to participate in upcoming investor conference
Neutral
Seeking Alpha
2 months ago
American Well Corporation (AMWL) Q4 2024 Earnings Call Transcript
American Well Corporation (NYSE:AMWL ) Q4 2024 Earnings Conference Call February 12, 2025 5:00 PM ET Company Participants Sue Dooley - Head of Investor Relations Ido Schoenberg - Chairman & Chief Executive Officer Mark Hirschhorn - Chief Financial Officer Conference Call Participants Craig Hettenbach - Morgan Stanley Stan Berenshteyn - Wells Fargo Securities Jailendra Singh - Truist Securities Eric Percher - Nephron Research Charles Rhyee - TD Cowen Matt Shea - Needham & Company Kevin Caliendo - UBS David Larsen - BTIG Jessica Tassan - Piper Sandler Operator Thank you for standing by and welcome to Amwell's Fourth Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
American Well Corporation (AMWL) Q4 2024 Earnings Call Transcript
Positive
Zacks Investment Research
2 months ago
Compared to Estimates, American Well (AMWL) Q4 Earnings: A Look at Key Metrics
Although the revenue and EPS for American Well (AMWL) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Compared to Estimates, American Well (AMWL) Q4 Earnings: A Look at Key Metrics
Negative
Zacks Investment Research
2 months ago
American Well Corporation (AMWL) Reports Q4 Loss, Tops Revenue Estimates
American Well Corporation (AMWL) came out with a quarterly loss of $2.77 per share versus the Zacks Consensus Estimate of a loss of $2.82. This compares to loss of $3.40 per share a year ago.
American Well Corporation (AMWL) Reports Q4 Loss, Tops Revenue Estimates
Neutral
GlobeNewsWire
2 months ago
Amwell® Announces Results for Fourth Quarter and Full Year 2024
BOSTON, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the fourth quarter and full year ended Dec. 31, 2024. Visit Amwell's investor relations website at investors.amwell.com to view the fourth quarter and full year 2024 earnings report.
Amwell® Announces Results for Fourth Quarter and Full Year 2024
Charts implemented using Lightweight Charts™